MEDICAL VENTURES
HOME COMPANY PRODUCTS NEWS & EVENTS INVESTORS CONTACT


LATEST NEWS

April 21, 2008
Medical Ventures targets July 1, 2008 to close acquisition

April 15, 2008
MEV announces FDA application update for Metricath Gemini

March 14, 2008
Medical Ventures reports 2007 results

February 15, 2008
Medical Ventures GAAME clinical update

 

 

 

 

 

 

 

 

 

 




 

 




 

 

 

 

 

 

 

 

 

Our business is quality of life.

Medical Ventures Corp. (TSX-V: MEV) is a medical devices company that develops, manufactures and commercializes clinical tools for the quickly growing vascular and surgical marketplace.

MEV products help doctors treat a wide range of health concerns, including vascular disease and obesity.

PeriPatch EQ Sheet PeriPatch Sheet Metricath Libra Metricath Gemini Metricath Libra CorRestore Patch Metricath Libra PeriPatch Sheet PeriPatch Sleeve Metricath Libra PeriPatch Sleeve Metricath Libra Metricath System Metricath Libra Metricath Libra
PeriPatch EQ Sheet
PeriPatch Sheet
Metricath Libra
Metricath Gemini
CorRestore Patch
PeriPatch Sheet
PeriPatch Sleeve
Metricath Libra
Metricath System

Medical Ventures is comprised of two product divisions:

Angiometrx Inc.develops catheter-based products for use in interventional cardiology procedures and the treatment of vascular disease.

PM Devices develops tissue-based products for general and specialized surgical applications.

MEV listed on the TSX

© 2005 Medical Ventures Corp. All rights reserved.